Should metformin be held before monitored anesthesia care (MAC) for a glaucoma procedure?

Should Metformin Be Held Before MAC Anesthesia for Glaucoma Procedure?

Yes, metformin should be stopped the night before your glaucoma procedure under MAC anesthesia, but this is a conservative approach for a minor procedure where the risk is extremely low in patients without risk factors.

Clinical Reasoning

The 2018 perioperative diabetes management guidelines provide clear direction: stop metformin the night before surgery 1. However, this recommendation was developed primarily for major surgery, and the context of a glaucoma procedure under MAC anesthesia requires nuanced interpretation.

Risk Stratification is Critical

The actual risk of metformin-associated lactic acidosis is exceedingly rare (2-9 per 100,000 patients/year) with a mortality rate of 30-50% when it does occur 1. The key is identifying patients at risk, not blanket discontinuation:

High-risk factors requiring metformin discontinuation:

• Creatinine clearance < 60 mL/min 1
• Severe heart failure (ejection fraction < 30%) 1
• Conditions that could impair renal function: dehydration, fasting, concurrent ACE inhibitors/ARBs, diuretics, or NSAIDs 1
• Planned use of iodinated contrast agents 1, 2
• Sepsis, hypoxia, or shock 2
• Hepatic impairment 3, 2

The Glaucoma Surgery Context

A glaucoma procedure under MAC anesthesia is fundamentally different from major surgery:

• Minimal hemodynamic stress - no significant fluid shifts or blood loss
• Short duration - typically 30-60 minutes
• Minimal fasting period - patients can usually resume oral intake quickly
• No contrast agents - unlike some imaging procedures
• Low risk of acute kidney injury - minimal physiologic perturbation

The FDA label emphasizes that metformin should be withheld "during surgical or other procedures" when "restricted food and fluid intake" increases risk of "volume depletion, hypotension, and renal impairment" 2. This scenario is unlikely in routine glaucoma surgery under MAC.

Practical Algorithm

For patients WITHOUT risk factors (normal renal function, no heart failure, well-hydrated):

• Hold metformin the morning of surgery (conservative approach)
• Resume same day or next morning once eating/drinking normally
• No need for 48-hour hold as recommended for major surgery 1

For patients WITH any risk factors listed above:

• Stop metformin the night before 1
• Do NOT restart until renal function confirmed stable
• Consider glucose monitoring if patient is NPO for extended period

For patients on high-dose metformin (>2000 mg/day) or elderly (>65 years):

• Stop the night before out of abundance of caution 1
• These populations had higher lactic acidosis rates in French surveillance data 1

Important Caveats

The evidence is contradictory: Some studies found no cases of lactic acidosis perioperatively 1, while others found cases only when risk factors were present 1. The Duncan study showed identical postoperative complications whether metformin was continued or not 1. Recent literature suggests metformin continuation may be safe for minor procedures 4, 5.

Detection bias exists: The guideline recommendation to "stop metformin the night before" was written for general surgical populations, not specifically for low-risk ophthalmic procedures 1.

Common pitfall: Unnecessarily prolonged metformin discontinuation (48+ hours) for minor procedures can worsen glycemic control without meaningful safety benefit. The 48-hour recommendation applies to major surgery 1, not brief outpatient procedures.

Coordination with Surgical Team

Verify with your ophthalmologist and anesthesiologist whether:

• The procedure involves iodinated contrast (rare in glaucoma surgery)
• Expected NPO duration exceeds 6-8 hours
• Patient has any of the high-risk features listed above

Bottom line: For a healthy patient with normal renal function undergoing routine glaucoma surgery under MAC, holding metformin the morning of surgery represents a reasonable, conservative approach that balances theoretical lactic acidosis risk against glycemic control 1, 4. Patients with risk factors require more cautious management with overnight discontinuation 1, 2.